Core Insights - SINTX Technologies has signed a supply agreement with Evonik Corporation to produce its proprietary SiN/PEEK composite material, enabling immediate production of AI-assisted patient-specific implants [1][2][3] - The SiN/PEEK material is designed for 3D printing of customized implants, addressing requests from doctors for vertebral body replacement implants for orthopedic and neurosurgical tumor patients [2][3] - The collaboration aims to combine Evonik's polymer manufacturing expertise with SINTX's silicon nitride biomaterials to meet critical clinical needs in trauma, spine, and oncology [2][3] Company Overview - SINTX Technologies, Inc. specializes in advanced ceramic materials, focusing on the development and commercialization of silicon nitride biomaterials and composites for medical applications [7] - The company has a strong patent portfolio and has developed thousands of medical devices since 2008, establishing itself as a leader in high-performance biomaterials [7] - SINTX is preparing to expand its production capabilities and regulatory submissions to address a broader range of indications beyond its current humanitarian focus [3][7] Material Advantages - SiN/PEEK offers superior pathogen-resistant surface properties, osteoconductive support, and enhanced imaging performance compared to standard PEEK [5][3] - The combination of silicon nitride and PEEK aims to provide additional clinical and economic value in complex implant indications [3][5] - The material supports greater design flexibility for patient-specific geometries through AI-assisted additive manufacturing [5][3] Strategic Collaboration - The agreement with Evonik is seen as a significant milestone for SINTX and the field of patient-specific implants, ensuring stable quality, reliable supply, and scalability for future collaborations [2][3] - Evonik's commitment to innovation in medical devices aligns with SINTX's goals to improve patient outcomes through advanced materials [2][3]